Ivermectin in COVID 19
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
A randomized, double-blind, placebo-controlled trial of ivermectin, an antiparasitic drug, for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in hospitalized adult patients (aged 18–80 years) between July 1, 2021 and October 31, 2021.
创建时间：
2022-02-02
